SCHEMBL20108897

SCHEMBL20108897

O=P(c1ccccc1)(c1ccccc1)c1ccc(-c2ccc3ccc4ccc(-c5ccncc5)nc4c3n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.46
AR P10275 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
NOTUM Q6P988 1/20 0.41
DHODH Q02127 1/20 0.40
PARP1 P09874 2/20 0.39
KDM4E B2RXH2 2/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 2/20 0.36
GSK3B P49841 2/20 0.36
CDC7 O00311 1/20 0.36
MAPT P10636 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17403775 0.91 PARP1 (0.46) NPC1RAB9APARP1KDM4EKMT2A
SCHEMBL17899346 0.85 NOTUM (0.58) CYP2C9ARNPC1RAB9ACYP1A2
SCHEMBL17403770 0.85 MMP2 (0.46) CYP3A4CYP2D6PARP1KDM4EMAPT
SCHEMBL17174105 0.85 PARP1 (0.46) RAB9APARP1KDM4EKMT2AMAPT
SCHEMBL17174126 0.85 PARP1 (0.39) ARNPC1RAB9ADHODHPARP1
SCHEMBL17174127 0.85 PARP1 (0.46) RAB9APARP1KDM4EKMT2AMAPT
SCHEMBL17174111 0.84 PARP1 (0.41) RAB9ADHODHPARP1KMT2AMAPT
SCHEMBL20108846 0.84 CYP1A1 (0.45) CYP2C9ARNPC1RAB9ACYP1A2
SCHEMBL20108905 0.83 CYP2C9 (0.39) CYP2C9ARNPC1RAB9ACYP1A2
SCHEMBL20108882 0.82 PARP1 (0.40) RAB9APARP1KMT2ACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2021-10-26 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD2, OCIAD1, PPOX CYP2C9 400/4885AR 3068/4885NPC1 1701/4885
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD2, OCIAD1, PPOX CYP2C9 400/4885AR 3068/4885NPC1 1701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.